The abstract is read at the publisher; the summary is JClub's.
In 5213 patients with acute pulmonary embolism, major bleeding occurred in 3.1% within 30 days, with 78 early (<7 days) and 81 late (≥7 days) events.
- Why it matters: Major bleeding is the key tradeoff for anticoagulant and thrombolytic treatment in acute PE, but predictors and risk patterns over time are not well separated.
- What they did: In a prospective multicentre COPE study, investigators used ISTH-defined major bleeding during 30-day follow-up, distinguishing early versus late events and testing bleeding risk scores and four bleeding-phenotypes.
- The result: Independent predictors differed by timing: early MB linked to active cancer, previous bleeding, dementia, anemia, syncope, and thrombolysis; late MB linked to active cancer, previous bleeding, and anemia, and phenotype-based prediction matched PE-SARD, BACS, and VTE-Bleed.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.